Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
absorption, answer, anticoagulant, APC, arose, Arrowhead, Avenue, biostatistical, bleeding, blunt, BMR, cascade, chicken, clot, clotting, coagulation, compensatory, composed, Concord, conspiracy, coordinated, counterclaim, covenant, dealing, deceptive, defamation, differentiation, disgorgement, dismissal, disorder, disseminate, dissociation, distract, DPC, dynamic, easier, endometrial, enrichment, enzyme, exemption, expert, explaining, faith, fibrin, fibrinogen, frame, geometric, globin, Goetz, hand, HBV, HDL, hemojuvelin, hemophilia, highest, histopathology, hypercholesteremia, hypertriglyceridemia, inactivation, incorrectly, indeterminate, input, insoluble, intermittent, intracellular, inventor, inventorship, juncture, KPMG, Kynamro, Leiden, levelsin, lowest, marked, Mason, MBA, Meltemi, MHRA, mild, misappropriation, mobilization, Nadir, nonrecognized, orderly, overload, Park, penalty, pendency, pharmacokinetic, phenotype, polyconjugate, Pond, porphyria, predicated, prejudice, professor, protease, prothrombotic, punitive, rash, readily, real, recurrent, regression, rental, reproduce, residual, restoration, retrospectively, ribavarin, sanofi, science, serine, settle, settled, shelf, sickle, slight, sodium, soluble, speed, spleen, streamline, stringent, subcutaneously, subletting, subtype, Supplementary, tendency, thrombin, Tothe, transferrin, transient, transmembrane, unbilled, unfair, unjust, Utah, Va, VaxiRNA, VIIIa, volunteer, Vyndaqel, Wilm
Removed:
abnormal, absorbing, acknowledged, aim, Allen, alleviation, allocated, annually, assign, attach, attachment, Avicena, backbone, billion, breaching, breakdown, chemoembolism, chemotherapy, cholinesterase, circulation, closed, cognitive, colorectal, constituent, contemplated, created, creatine, croup, demonstration, dietary, Dimebontm, disappointing, distribute, diversify, doctor, documented, encoded, erosion, experimental, extrahepatic, fallen, feature, FoldRx, fortreatmentof, functionality, Genta, German, globulin, glutamate, gut, HCC, hTTR, inconvenient, inexorable, innovative, inRule, intensive, InterfeRxtm, invalidity, investigated, knockdown, Kulmbach, leukoencephalopathy, machine, Medivation, mice, misfolding, mitochondrial, mouse, movement, MPTP, multifocal, neoplasm, nerve, neurobehavioral, neuroprotective, NMDA, onForm, orally, pace, Parkinson, Patricia, permeability, physically, PML, pneumonia, pore, predicted, purported, resectable, resection, retention, RXi, severest, Stanford, supportive, suppressing, suppression, thepreventionof, tolerate, transgenic, transition, uncomfortable, uncured, undisclosed, wind
Filing tables
Filing exhibits
- 10-K Annual report
- 10.19 Fourth Amendment to Lease, Dated November 4, 2011
- 10.20 Sublease Made As of August 3, 2010
- 12 Computation of Consolidated Ratios of Earnings/deficiencies to Fixed Charges
- 21.1 Subsidiaries of the Registrant
- 23.1 Consent of Pricewaterhousecoopers LLP
- 23.2 Consent of Ernst & Young LLP
- 31.1 Section 302 Certification of Chief Executive Officer
- 31.2 Section 302 Certification of Vice President of Finance and Treasurer
- 32.1 Section 906 Certification of Chief Executive Officer
- 32.2 Section 906 Certification of Vice President of Finance and Treasurer
- 99.1 Report of Ernst & Young LLP (Re: Regulus Therapeutics Inc.)
Related press release
ALNY similar filings
Filing view
External links